Raymond M. Jordt, M.B.A.

Raymond M. Jordt, M.B.A.

Chief Business OfficeratAltimmune· In proxies 2022–2023

Pay in FY2022Altimmune stock +79.6% the same year

Raymond M. Jordt, M.B.A. was paid $0 in FY2022 (Dec). Altimmune stock rose 79.6% that year.

Pay$100 in the stock at the end of FY21 → $180
Pay is from the Summary Compensation Table of each Altimmune proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AltimmunePublic company · 4 yr
    • Chief Business Officer2022 – Present · 4 yrStock in role -76%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?